Artificial intelligence-based tumor size measurement on mammography: agreement with pathology and comparison with human readers’ assessments across multiple imaging modalities
- 20 June 2025
- journal article
- research article
- Published by Springer Nature in La radiologia medica
- p. 1-13
Abstract
Purpose To evaluate the agreement between artificial intelligence (AI)-based tumor size measurements of breast cancer and the final pathology and compare these results with those of other imaging modalities. Material and methods This retrospective study included 925 women (mean age, 55.3 years ± 11.6) with 936 breast cancers, who underwent digital mammography, breast ultrasound, and magnetic resonance imaging before breast cancer surgery. AI-based tumor size measurement was performed on post-processed mammographic images, outlining areas with AI abnormality scores of 10, 50, and 90%. Absolute agreement between AI-based tumor sizes, image modalities, and histopathology was assessed using intraclass correlation coefficient (ICC) analysis. Concordant and discordant cases between AI measurements and histopathologic examinations were compared. Results Tumor size with an abnormality score of 50% showed the highest agreement with histopathologic examination (ICC = 0.54, 95% confidential interval [CI]: 0.49–0.59), showing comparable agreement with mammography (ICC = 0.54, 95% CI: 0.48–0.60, p = 0.40). For ductal carcinoma in situ and human epidermal growth factor receptor 2-positive cancers, AI revealed a higher agreement than that of mammography (ICC = 0.76, 95% CI: 0.67–0.84 and ICC = 0.73, 95% CI: 0.52–0.85). Overall, 52.0% (487/936) of cases were discordant, with these cases more commonly observed in younger patients with dense breasts, multifocal malignancies, lower abnormality scores, and different imaging characteristics. Conclusion AI-based tumor size measurements with abnormality scores of 50% showed moderate agreement with histopathology but demonstrated size discordance in more than half of the cases. While comparable to mammography, its limitations emphasize the need for further refinement and research.Keywords
This publication has 31 references indexed in Scilit:
- ACR Appropriateness Criteria® Female Breast Cancer Screening: 2023 UpdateJournal of the American College of Radiology, 2024
- Artificial Intelligence for Breast Cancer Detection on Mammography: Factors Related to Cancer DetectionAcademic Radiology, 2024
- Depiction of breast cancers on digital mammograms by artificial intelligence-based computer-assisted diagnosis according to cancer characteristicsEuropean Radiology, 2022
- Independent External Validation of Artificial Intelligence Algorithms for Automated Interpretation of Screening Mammography: A Systematic ReviewJournal of the American College of Radiology, 2022
- Digital breast tomosynthesis (DBT) plus synthesised two-dimensional mammography (s2D) in breast cancer screening is associated with higher cancer detection and lower recalls compared to digital mammography (DM) alone: results of a systematic review and meta-analysisEuropean Radiology, 2021
- Evaluation of Combined Artificial Intelligence and Radiologist Assessment to Interpret Screening MammogramsJAMA Network Open, 2020
- The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancerBreast Cancer Research and Treatment, 2018
- Comparison of recommendations for screening mammography using CISNET modelsCancer, 2017
- Predicting the survival of patients with breast carcinoma using tumor sizeCancer, 2002
- Correlating sonography, mammography, and pathology in the assessment of breast cancer sizeThe American Journal of Surgery, 2001